Literature DB >> 10708422

Mengovirus and encephalomyocarditis virus poly(C) tract lengths can affect virus growth in murine cell culture.

L R Martin1, Z C Neal, M S McBride, A C Palmenberg.   

Abstract

Many virulent aphthoviruses and cardioviruses have long homopolymeric poly(C) tracts in the 5' untranslated regions of their RNA genomes. A panel of genetically engineered mengo-type cardioviruses has been described which contain a variety of different poly(C) tract lengths. Studies of these viruses have shown the poly(C) tract to be dispensable for growth in HeLa cells, although the relative murine virulence of the viruses correlates directly and positively with tract length. Compared with wild-type mengovirus strain M, mutants with shortened poly(C) tracts grow poorly in mice and protectively immunize rather than kill recipient animals. In the present study, several murine cell populations were tested to determine whether, unlike HeLa cells, they allowed a differential amplification of viruses with long or short poly(C) tracts. Replication and cytopathic studies with four hematopoietically derived cell lines (CH2B, RAW 264.7, A20.J, and P815) and two murine fibroblast cell lines [L929 and L(Y)] demonstrated that several of these cell types indeed allowed differential virus replication as a function of viral poly(C) tract length. Among the most discerning of these cells, RAW 264.7 macrophages supported vigorous lytic growth of a long-tract virus, vMwt (C(44)UC(10)), but supported only substantially diminished and virtually nonlytic growth of vMC(24) (C(13)UC(10)) and vMC(0) short-tract viruses. The viral growth differences evident in all cell lines were apparent early and continuously during every cycle of virus amplification. The data suggest that poly(C) tract-dependent attenuation of mengovirus may be due in part to a viral replication defect manifest in similar hematopoietic-type cells shortly after murine infection. The characterized cultures should provide excellent tools for molecular study of poly(C) tract-mediated virulence.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10708422      PMCID: PMC111806          DOI: 10.1128/jvi.74.7.3074-3081.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Induction of high titer chicken interferon.

Authors:  M J Sekellick; P I Marcus
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

2.  Characterization of genetically engineered mengoviruses in mice.

Authors:  J E Osorio; S E Grossberg; A C Palmenberg
Journal:  Viral Immunol       Date:  2000       Impact factor: 2.257

3.  Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase.

Authors:  J Kitajewski; R J Schneider; B Safer; S M Munemitsu; C E Samuel; B Thimmappaya; T Shenk
Journal:  Cell       Date:  1986-04-25       Impact factor: 41.582

Review 4.  Role of macrophages in natural resistance to virus infections.

Authors:  S C Mogensen
Journal:  Microbiol Rev       Date:  1979-03

5.  A mechanism for the control of protein synthesis by adenovirus VA RNAI.

Authors:  R P O'Malley; T M Mariano; J Siekierka; M B Mathews
Journal:  Cell       Date:  1986-02-14       Impact factor: 41.582

6.  Preparation and characterization of encephalomyocarditis (EMC) virus.

Authors:  R R Rueckert; M A Pallansch
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

7.  Structural requirements of double-stranded RNA for the activation of 2',5'-oligo(A) polymerase and protein kinase of interferon-treated HeLa cells.

Authors:  M A Minks; D K West; S Benvin; C Baglioni
Journal:  J Biol Chem       Date:  1979-10-25       Impact factor: 5.157

8.  The immunogenic and pathogenic potential of short poly(C) tract Mengo viruses.

Authors:  J E Osorio; L R Martin; A C Palmenberg
Journal:  Virology       Date:  1996-09-15       Impact factor: 3.616

9.  Protection of non-murine mammals against encephalomyocarditis virus using a genetically engineered Mengo virus.

Authors:  J E Osorio; G B Hubbard; K F Soike; M Girard; S van der Werf; J C Moulin; A C Palmenberg
Journal:  Vaccine       Date:  1996-02       Impact factor: 3.641

10.  Attenuated Mengo virus as a vector for immunogenic human immunodeficiency virus type 1 glycoprotein 120.

Authors:  R Altmeyer; N Escriou; M Girard; A Palmenberg; S van der Werf
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

View more
  15 in total

1.  Pathogenicity and molecular analysis of an encephalomyocarditis virus isolate from mideastern China.

Authors:  Juan Bai; Kangfu Jiang; Guolong Zhang; Xianwei Wang; Yufeng Li; Ping Jiang
Journal:  Can J Vet Res       Date:  2012-04       Impact factor: 1.310

2.  Terminal RNA replication elements in human parechovirus 1.

Authors:  Abdolrahman S Nateri; Pamela J Hughes; Glyn Stanway
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Poliovirus 3A protein limits interleukin-6 (IL-6), IL-8, and beta interferon secretion during viral infection.

Authors:  D A Dodd; T H Giddings; K Kirkegaard
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

4.  Encephalomyocarditis virus induces PKR-independent mitogen-activated protein kinase activation in macrophages.

Authors:  Jason M Moran; Michael A Moxley; R Mark L Buller; John A Corbett
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  A wild-type porcine encephalomyocarditis virus containing a short poly(C) tract is pathogenic to mice, pigs, and cynomolgus macaques.

Authors:  Rebecca LaRue; Suzanne Myers; Laurie Brewer; Daniel P Shaw; Corrie Brown; Bruce S Seal; M Kariuki Njenga
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

6.  Discovery of a novel human picornavirus in a stool sample from a pediatric patient presenting with fever of unknown origin.

Authors:  Morris S Jones; Vladimir V Lukashov; Robert D Ganac; David P Schnurr
Journal:  J Clin Microbiol       Date:  2007-04-25       Impact factor: 5.948

7.  Binding interactions between the encephalomyocarditis virus leader and protein 2A.

Authors:  Ryan V Petty; Holly A Basta; Valjean R Bacot-Davis; Bradley A Brown; Ann C Palmenberg
Journal:  J Virol       Date:  2014-09-10       Impact factor: 5.103

Review 8.  The encephalomyocarditis virus.

Authors:  Margot Carocci; Labib Bakkali-Kassimi
Journal:  Virulence       Date:  2012-06-22       Impact factor: 5.882

9.  New Saffold cardioviruses in 3 children, Canada.

Authors:  Yacine Abed; Guy Boivin
Journal:  Emerg Infect Dis       Date:  2008-05       Impact factor: 6.883

10.  A rat model of picornavirus-induced airway infection and inflammation.

Authors:  Louis A Rosenthal; Svetlana P Amineva; Renee J Szakaly; Robert F Lemanske; James E Gern; Ronald L Sorkness
Journal:  Virol J       Date:  2009-08-11       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.